ArticleTherapeutic advances in neurological disorders2025

Application of efgartigimod in Chinese patients with myasthenia gravis: a single-center real-world prospective study.

Geke Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.